Innovative breakthrough in Medtech that will change the landscape in the medical profession.
Thursday, July 14th, at 12:00 BST / 13:00 CEST / 07:00 EDT / 04:00 PDT
Diagnosing, treating and managing clinically similar respiratory infections can be challenging. Flu, RSV and SARS-CoV-2 all present with similar symptoms.
It is important to be able to provide clear differential diagnosis for respiratory infections and enable rapid triage and effective treatment strategies, particularly in at-risk groups of patients. Flu, RSV and SARS-CoV-2 therapies require detection for each individual pathogen and identification of co-infection is important.
Attendees are invited to join an expert panel who will discuss the need for rapid, accurate PCR respiratory panels and present new data from a newly available rapid point of care PCR panel from QuantuMDx.
The newly available panel delivers rapid PCR results in 35 minutes at the Point of Care providing healthcare professionals the tools they need to treat efficiently and effectively with on demand accurate results.
Who should attend
- Infectious disease specialists
- Molecular specialists
- Laboratory managers
- Laboratory technicians
- Respiratory clinicians
- Emergency room clinicians
- Innovation leads
- POC co-ordinators
Key learning objectives
- Understand the importance of rapid PCR respiratory infection testing at the Point of Care
- Discover a new rapid PCR respiratory testing solution, as we look to the future of respiratory disease management
- Learn about the performance of this new tool from experts in the field
- Feel ready to sustainably integrate Point of Care testing in busy healthcare settings
- Prepare for flu season and for seasonal respiratory infection management
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
